High materiality7/10
Tango Therapeutics price target raised to $35 from $32 at Guggenheim
Why it may matterVerify against the original reporting
Buy on upgrade signaling upside.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Guggenheim raises TNGX target to $35; current price reported at $26.34.
- TNGX target up to 35
- TNGX price $26.34
Key facts
- 01
Target: $35
- 02
Posted price: $26.34
- 03
Analyst firm: Guggenheim
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.